| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |